ArticleJournal of the Optical Society of America. A, Optics, image science, and vision2025
iPhone-based anomaloscope for accessible, accurate color vision testing.
Article in Journal of the Optical Society of America. A, Optics, image science, and vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Rapid test for detecting red-green color vision deficiencies using a neural network-assisted color-naming task.Scientific reports · 2026Article
- Assessment of the Penn anomaloscope.Biomedical optics express · 2025Article
- A Global Perspective of Color Vision Deficiency: Awareness, Diagnosis, and Lived Experiences.Healthcare (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Red-green color vision deficiency (CVD) is the most common single-locus genetic disorder in humans, but our ability to accurately diagnose the subtype and severity of red-green CVD in the clinic is limited. The most widely used diagnostic tools are subject to both Type I and Type II errors, while highly accurate tests are expensive, time-consuming, and not widely available. In this study, we present an iPhone-based color matching test that uses a combination of optics and software to achieve the diagnostic accuracy of an anomaloscope and the convenience of pseudoisochromatic plates. In validation testing, the device correctly diagnosed 100% of participants, as verified by genetic testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.